{rfName}
Ef

License and Use

Icono OpenAccess

Altmetrics

Analysis of institutional authors

Galvez Escañuela, JordiAuthor

Share

February 12, 2018
Publications
>
Letters

Efficacy and Safety of Fosfomycin Plus Imipenem vs. Vancomycin for Complicated Bacteremia and Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: A Randomized Clinical Trial.

Publicated to: Clinical Microbiology And Infection. 24 (6): 673-676 - 2018-06-01 24(6), DOI: 10.1016/j.cmi.2018.01.010

Authors: Pericás, JM; Moreno, A; Almela, M; García-de-la-Mària, C; Marco, F; Muñoz, P; Peña, C; de Alarcón, A; del Río, A; Eworo, A; Cruceta, A; Paré, JC; Mestres, CA; Miró, JM

Affiliations

Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain - Author
HU Virgen Rocio, Inst Biomed Sevilla IBiS,CSIC, UGC Enfermedades Infecciosas Microbiol & Med Prev, Infect Dis Serv,Grp Invest Enfermedades Infeccios, Seville, Spain - Author
Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Infect Dis Serv, Barcelona, Spain - Author
Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Microbiol Dept, Barcelona, Spain - Author
Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi i Sunyer, Cardiol Dept, Barcelona, Spain - Author
Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi i Sunyer, Clin Trials Unit, Barcelona, Spain - Author
Univ Barcelona, IDIBELL, Hosp Bellvitge, Infect Dis Serv, Lhospitalet De Llobregat, Spain - Author
Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid, Spain - Author
Univ Zurich, Univ Hosp Zurich, Dept Cardiovasc Surg, Zurich, Switzerland - Author
See more

Keywords

BacteremiaEndocarditisFosfomycinImipenemMrsaVancomycin alternatives

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Clinical Microbiology And Infection due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2018, it was in position 6/89, thus managing to position itself as a Q1 (Primer Cuartil), in the category Infectious Diseases. Notably, the journal is positioned above the 90th percentile.

Independientemente del impacto esperado determinado por el canal de difusión, es importante destacar el impacto real observado de la propia aportación.

Según las diferentes agencias de indexación, el número de citas acumuladas por esta publicación hasta la fecha 2025-12-13:

  • WoS: 19
  • Scopus: 22
  • Europe PMC: 6

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-12-13:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 69.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 70 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 8.
  • The number of mentions on the social network Facebook: 2 (Altmetric).
  • The number of mentions on the social network X (formerly Twitter): 8 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Switzerland.